Table 1.
Patients 204 (♀ 86, ♂ 118) | Average | Range |
---|---|---|
Age (years) | 64.8 | 25–91 |
BMI (kg/cm2) | 26.3 | 14.7–38.9 |
Glycemia (mg/ml) | 103.5 | 52–232 |
Injected dose (MBq) | 296 | 133–494 |
Uptake time (min) | 59 | 51–100 |
Clinical indications Oncological: 199 Non-oncological: 5 |
||
Follow-up (months) | 5.3 | 3–12 |